US FDA Accepts Revised Application for Sanofi's Inflammatory Skin Disease Drug
US FDA Accepts Revised Application for Sanofi's Inflammatory Skin Disease Drug
美国食品药品监督管理局接受赛诺菲安万特公司治疗炎症性皮肤病药物的修订申请
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间